CD79A and B-cell chronic lymphocytic leukemia: Levels of IgG and IgA anti RBD in CLL patients were sensibly lower than in HCW used as control (p < 0.0001) (Fig. 1A–B, C–D, E–F and Supplementary Figure 1).